× Medicines Discovery Catapult

We’re looking to support Biomedical Catalyst: Developmental Pathway Funding Scheme (DPFS) applications with industry and commercial expertise and services.

Summary

DPFS is an ongoing scheme, with outline deadlines every 4 months. The scheme is a key part of our Translational Research Strategy and supports the translation of fundamental discoveries toward benefits to human health. It funds the pre-clinical development and early clinical testing of novel therapeutics, devices and diagnostics, including “repurposing” of existing therapies.

Closes: Wednesday 22nd July 2020
Organisation: MRC
Guidelines: Read the full competition details >

Why partner with the Medicines Discovery Catapult?

  • Our experienced commercial and scientific teams have connections across industry, academia, finance, government, and research networks – we can help take your projects further towards commercial viability.
  • We have specialist grant writing expertise to work with you in crafting grant applications.
  • Our team has a wealth of industrial and academic expertise applied to drug discovery, complex cell models, assay development, biomarker identification, and validation.
  • You’ll have supported access, with specialist expertise, to groundbreaking technologies including multi-omics capabilities, mass spec quantitation, mass spec imaging, and organ-on-a-chip capabilities.
  • Our team are experts in translating analytical methodologies that are sensitive, specific, and robust for clinical utility.
  • Our Informatics team has deep expertise in natural language processing, data analysis, machine learning, cheminformatics, and bioinformatics.
  • We can provide access to information that’s not readily available around target validation, drug target interaction, and downstream consequences of engagement.
  • We can help unlock access to appropriately consented patient Samples & Data.
  • We’ll give you access to a network of clinical, academic, and industry experts via Virtual R&D.
Share